Simple Summary Cisplatin is a chemotherapy drug extensively used to treat cancer,
improving the survival of cancer patients. Although effective for this purpose, its use is …

Chemotherapy-induced peripheral neuropathic pain (CIPN) is a common and severe
debilitating side effect of many widely used cytostatics. However, there is no approved …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major concern in oncology
practice given the increasing number of cancer survivors and the lack of effective treatment …

Cisplatin, oxaliplatin, paclitaxel, vincristine and bortezomib are some of the most effective
drugs successfully employed (alone or in combinations) as first-line treatment for common …

Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic
cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far …

Background Peripheral neuropathy is the major dose-limiting side effect of cisplatin and
oxaliplatin, and there are currently no effective treatments available. The aim of this study …

Chemotherapy-induced peripheral neuropathy (CIPN) is common in patients receiving
anticancer treatment and can affect survivability and long-term quality of life of the patient …

Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling side effect
of various chemotherapeutic agents, including oxaliplatin. It is highly prevalent amongst …

Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting side effect
experienced by patients receiving treatment for cancer. Approximately 30 to 40% of patients …